← Evidence map

ArticleAnti-cancer drugs2018

Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine.

Kevin J Church et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2018
2019
2020
2021
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29389804